Medical history review
Before any prescription is issued, Dr. Anjmun Sharma, MD reviews the submitted medical history, current medications, and contraindications.
How we keep you safe: physician supervision by Dr. Sharma, contraindication screening, baseline labs, standard titration, and side-effect management. See our clinical standards.
FDA-approved tirzepatide products have product-specific evidence for defined indications. Tirzepatide is a non-surgical, prescription weight loss option available by telehealth. Here's how its dual mechanism works, what it costs at New Hope Weight Loss, and how to start under real physician supervision.

Tirzepatide is a dual-action prescription medication that works on two gut-hormone pathways (GLP-1 and GIP) to reduce appetite. New Hope Weight Loss prescribes physician-supervised compounded tirzepatide by telehealth, with 90-day programs from $233 per month · just $7.70/day and no insurance needed. A $119 consultation with a licensed physician gets you started. Compounded tirzepatide is a different product from the FDA-approved brands, and results vary. You can check your eligibility online in about two minutes.
Important: Compounded semaglutide and tirzepatide are not FDA-approved and are not brand-identical. Eligibility and results vary.
Costs less than a coffee and a pastry.
$233 a month, physician-supervised, no insurance needed.
Tirzepatide is a dual GIP/GLP-1 receptor agonist, it activates two gut-hormone pathways instead of one. That dual action produces even stronger appetite suppression and metabolic effects than semaglutide alone for many patients.
Tirzepatide is the active ingredient in the brand-name products Mounjaro® and Zepbound®. The dispensing pharmacy label identifies the compounded preparation as tirzepatide. It is a different product from FDA-approved brands, is not FDA-approved or brand-identical, and results vary. Each prescription requires Dr. Sharma's review.
See if you qualify, free 2-minute quiz →
For context, SURMOUNT-1 reported an average 20.9% at 72 weeks for brand tirzepatide 15 mg. That result does not predict response to compounded tirzepatide, which is not FDA-approved or brand-identical. Results vary, and the appropriate option depends on physician review, tolerability, access, and total cost.
Tirzepatide may be considered if you have more weight to lose or have not responded fully to semaglutide, but the choice depends on clinical fit and tolerability. Dr. Sharma evaluates your goals, history, and contraindications individually and helps you choose. Both options include the same physician oversight and bilingual advisor support.
The dispensing pharmacy label identifies the compounded preparation as tirzepatide. It is a different product from FDA-approved brands, is not FDA-approved or brand-identical, and results vary. It is subject to patient-specific and location-specific dispensing-pharmacy verification operating under section 503A and is not an FDA-approved product; the brand-name versions are. Every prescription at New Hope Weight Loss is physician-supervised.
In their respective pivotal trials, tirzepatide produced greater average weight loss than semaglutide (about 20.9% in SURMOUNT-1 vs 14.9% in STEP 1 at top doses). It is not automatically the right choice for everyone, Dr. Sharma weighs your goals, tolerance, and history to recommend the best fit.
At New Hope Weight Loss the doctor review is $119 one-time and a 3-month tirzepatide plan is $699 ($233/month). HSA/FSA and Klarna/Affirm are accepted. No insurance is required.
New Hope Weight Loss is in Costa Mesa, CA and provides telehealth care for eligible California patients. If a prescription is approved, the dispensing pharmacy must separately confirm whether it can fulfill for the patient and location, plus packaging and any shipping details before fulfillment.
Before any prescription is issued, Dr. Anjmun Sharma, MD reviews the submitted medical history, current medications, and contraindications.
Completing an intake or consultation does not guarantee a prescription. Eligibility, medication choice, and dose are determined individually.
If treatment is prescribed, follow-up addresses tolerability, symptoms, nutrition, hydration, and any dose changes.
Compounded semaglutide and tirzepatide are not FDA-approved and not brand-identical. Results vary by individual.
About $7.70 a day, less than a coffee and a pastry
A fraction of brand-name GLP-1 list prices, which often run $900 to $1,300 or more a month.
$119 one-time to get started with your physician consultation.
Medical disclaimer: Individual results may vary. GLP-1 medications require a physician prescription and ongoing supervision. Clinical trial results cited are averages; not all patients achieve the same outcomes. Eligibility is determined during the medical consultation. This information does not replace professional medical advice.
New Hope Weight Loss | 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location.
The efficacy figures on this page come from product-specific randomized trials of FDA-approved brand drugs, not compounded preparations. Compounded medications are not FDA-approved or brand-identical, and individual results vary.